Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
INCR | US
-0.03
-2.94%
Healthcare
Drug Manufacturers-Specialty & Generic
30/06/2024
08/06/2026
0.99
1.01
1.02
0.97
InterCure Ltd. together with its subsidiaries engages in the research cultivation production and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya Israel.
View LessLow Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Price Below SMA10D
High Short-term Volatility
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
121.4%1 month
86.6%3 months
64.6%6 months
64.1%-
6.94
0.65
0.29
0.18
5.29
1.58
-
2.95M
45.31M
45.31M
-
8.20
-84.70
-38.60
-13.61
0.82
0.08
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.33
Range1M
0.42
Range3M
0.51
Rel. volume
0.85
Price X volume
27.25K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Rani Therapeutics Holdings Inc. Class A Common Stock | RANI | Biotechnology | 0.8396 | 48.59M | 1.22% | n/a | 1243.32% |
| Cognition Therapeutics Inc. Common Stock | CGTX | Biotechnology | 1.21 | 48.56M | -6.20% | n/a | 2.71% |
| Mereo BioPharma Group plc | MREO | Biotechnology | 0.305 | 46.93M | -2.62% | n/a | 7.83% |
| Nuo Therapeutics Inc | AURX | Biotechnology | 1 | 46.60M | -13.79% | n/a | 0.00% |
| NRXP | NRXP | Biotechnology | 4.33 | 46.55M | 4.59% | n/a | -46.73% |
| BioXcel Therapeutics Inc | BTAI | Biotechnology | 1.105 | 45.02M | 0.00% | n/a | -139.46% |
| PEPG | PEPG | Biotechnology | 1.35 | 44.00M | -4.26% | n/a | 12.52% |
| Acrivon Therapeutics Inc. | ACRV | Biotechnology | 1.41 | 43.67M | -1.40% | n/a | 1.95% |
| Entera Bio Ltd | ENTX | Biotechnology | 1.2 | 43.59M | 1.69% | n/a | 3.91% |
| QNCX | QNCX | Biotechnology | 1 | 43.28M | -0.99% | n/a | 30.62% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Culp Inc | CULP | Textile Manufacturing | 3.09 | 38.60M | -2.22% | n/a | 11.29% |
| Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 1.1 | 16.07M | 7.84% | 0.03 | 16.03% |
| REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 0.4131 | 7.98M | -3.48% | n/a | 58.43% |
| EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.49 | 3.81M | 12.88% | n/a | 17.32% |
| Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.0058 | 534.84K | n/a | -37.05% | |
| Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 0.4181 | 230.37K | 7.87% | n/a | 0.00% |
| Blackstone/GSO Senior Floating Rate Term Fund | BSL | Textile Manufacturing | 12.915 | 0 | 0.19% | n/a |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 5.29 | 24.85 | Cheaper |
| Ent. to Revenue | 1.58 | 361.91 | Cheaper |
| PE Ratio | - | 30.05 | - |
| Price to Book | 0.65 | 13.15 | Cheaper |
| Dividend Yield | - | 2.94 | - |
| Std. Deviation (3M) | 64.61 | 65.24 | Par |
| Debt to Equity | 0.29 | -1.88 | Expensive |
| Debt to Assets | 0.18 | 0.48 | Cheaper |
| Market Cap | 45.31M | 3.71B | Emerging |